Trial Profile
A trial to evaluate impact of number of cycles of Collagenase Clostridium Histolyticum on outcomes in patients with Peyronie's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Peyronie's disease
- Focus Therapeutic Use
- 01 Jun 2016 New trial record
- 10 May 2016 Results presented at the 111th Annual Meeting of the American Urological Association